🇺🇸 FDA
Pipeline program

Aramchol

Aramchol006

Phase 2 small_molecule terminated

Quick answer

Aramchol for Gallstones is a Phase 2 program (small_molecule) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Galmed Pharmaceuticals
Indication
Gallstones
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials